MedTrace Logo

Development of a NIPTT for Detecting Copy Number Variations

NCT04774640 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2023-08-09

No results posted yet for this study

Summary

To collect whole blood samples from pregnant women for the purpose of developing, optimizing and evaluating laboratory-developed noninvasive prenatal test (NIPT) for the detection of fetal chromosomal abnormalities of interest defined as microinsertions, microdeletions and other copy number variations (CNVs). The NIPT result will be compared to the test results obtained by microarray analysis of fetal cellular material obtained by amniocentesis or chorionic villus sampling.

Conditions

  • Copy Number Variations

Interventions

DEVICE

MaterniT GENOME

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-29
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04774640 on ClinicalTrials.gov